Biblio
Mosunetuzumab and lymphoma: latest updates from 2022 ASH annual meeting. J Hematol Oncol. 2023;16(1):69.
. T cells expressing CD123 chimeric antigen receptors for treatment of acute myeloid leukemia. Curr Opin Hematol. 2015;22(6):484-488.
.